Neurocrine Biosciences | Nettoindtægt



Net Income Lave om Dato
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Cytokinetics USD -150020000 10.52M 2024-12
Dynavax Technologies USD 7.05M 10.54M 2024-12
Exelixis USD 139.86M 21.89M 2025-01
Gilead Sciences USD 1.78B 529M 2024-12
Halozyme Therapeutics USD 118.1M 18.92M 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prothena USD -57956000 1.04M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Repligen USD 5.83M 39.7M 2025-03
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Teva Pharmaceutical Industries USD -217000000 220M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Neurocrine Biosciences Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.